Atlas Trials

AZD9291 in Combination With Ascending Doses of Novel Therapeutics

Clinical trial NCT02143466 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02143466
Sponsor
AstraZeneca
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Non Small Cell Lung Cancer
Start date
2014-08-05
Primary completion
2020-03-04
Enrollment
344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.